Rtw Investments, LP Solid Biosciences Inc. Transaction History

Rtw Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.82 - $12.9 $410,425 - $1.88 Million	-145,541 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.33 - $11.64 $1,368 - $3,678	316 Added 0.22%	145,541 $1.51 Million
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $15,589 - $34,330	3,389 Added 2.39%	145,225 $835,000
Q1 2019 May 15, 2019	BUY	$7.19 - $32.37 $59,892 - $269,642	8,330 Added 6.24%	141,836 $1.31 Million
Q4 2018 Feb 14, 2019	SELL	$21.32 - $46.34 $2.75 Million - $5.97 Million	-128,812 Reduced 49.11%	133,506 $3.58 Million

Q3 2018 Nov 14, 2018	SELL	$36.35 - $51.7 $15 Million - $21.4 Million	-413,453 Reduced 61.18%	262,318 $12.4 Million
Q1 2018 May 14, 2018	BUY	$7.19 - $33.17 $4.86 Million - $22.4 Million	675,771 New	675,771 $4.61 Million

12.2K

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $31.7M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.